Sonder Capital Closes Futures II Fund with Mayo Clinic, Sutter Health Targeting AI-Enabled Robotics
Sonder Capital, led by Intuitive Surgical co-founder Fred Moll and Jay Watkins, closed its second fund, Futures II, with backing from Mayo Clinic and Sutter Health. Futures II will target AI-enabled medical robotics and minimally invasive therapies, potentially accelerating competition and innovation in robotic surgery markets served by Intuitive Surgical.
1. Sonder Capital Closes Futures II Fund
Sonder Capital, co-founded by Jay Watkins and Fred Moll, has completed the final close of its second venture fund, Futures II, securing commitments from major healthcare systems including Mayo Clinic and Sutter Health. This milestone underscores institutional investors’ confidence in next-generation healthcare technologies.
2. Focus on AI-Enabled Medical Robotics and Therapies
Futures II will deploy capital to startups developing AI-enabled medical robotics and minimally invasive therapies, aiming to establish new care pathways outside traditional hospital settings. The strategy prioritizes solutions that enhance automation, precision and patient outcomes in surgical and distributed care models.
3. Implications for Intuitive Surgical
With Sonder Capital’s founders originating from Intuitive Surgical, the influx of new funding into robotics startups could yield both competitive threats and collaboration opportunities for Intuitive Surgical. Emerging portfolio companies may become partners or rivals as they commercialize technologies in overlapping markets.
4. Stock Trending Among Retail Investors
Intuitive Surgical has recently emerged as a trending stock on major retail investor platforms, reflecting elevated interest in its market-leading robotic surgery systems despite no fresh financial updates. Increased attention suggests investor optimism about long-term growth prospects in medical robotics.